Tcg Crossover Management, LLC Entrada Therapeutics, Inc. Transaction History
Tcg Crossover Management, LLC
- $771 Million
- Q3 2024
A detailed history of Tcg Crossover Management, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 584,955 shares of TRDA stock, worth $7.42 Million. This represents 1.21% of its overall portfolio holdings.
Number of Shares
584,955
Previous 584,955
-0.0%
Holding current value
$7.42 Million
Previous $8.34 Million
12.21%
% of portfolio
1.21%
Previous 1.25%
Shares
3 transactions
Others Institutions Holding TRDA
# of Institutions
102Shares Held
28.1MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$61.7 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$56.1 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$55.9 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$38.7 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$21.7 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $398M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...